Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H7NO2 |
Molecular Weight | 137.136 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=C(C=CC=C1)C(O)=O
InChI
InChIKey=RWZYAGGXGHYGMB-UHFFFAOYSA-N
InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10)
DescriptionSources: http://www.dailyhealthmagazine.com/vitamin-l1/https://www.drugs.com/inactive/aminobenzoate-sodium-185.htmlCurator's Comment: description was created based on several sources, including:
DOI: 10.2174/157017906777934926 | https://www.ncbi.nlm.nih.gov/pubmed/12844171
Sources: http://www.dailyhealthmagazine.com/vitamin-l1/https://www.drugs.com/inactive/aminobenzoate-sodium-185.html
Curator's Comment: description was created based on several sources, including:
DOI: 10.2174/157017906777934926 | https://www.ncbi.nlm.nih.gov/pubmed/12844171
Sodium anthranilate is an excipient (pharmacologically inactive substance). Sodium anthranilate (Aminobenzoate sodium ,C7H6NNaO2), also known as sodium 2-aminobenzoate, is an organic amine. Aminobenzoate sodium exists as a yellow powder for use in pharmaceutical processing.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Anthranilate hydroxylase Sources: http://www.genome.jp/dbget-bin/www_bget?ec:1.14.16.3 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | Desoxyn Approved UseDesoxyn is used in the treatment of adhd; obesity and belongs to the drug classes anorexiants, CNS stimulants. Launch Date1943 |
|||
Diagnostic | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. | 2001 |
|
Electrophoretic sequencing of heparin/heparan sulfate oligosaccharides using a highly sensitive fluorescent end label. | 2001 Feb |
|
Enhanced biodegradation of petrochemical wastewater using ozonation and BAC advanced treatment system. | 2001 Mar |
|
Effects of the butylated hydroxyanisole and butylated hydroxytoluene on the DNA adduct formation and arylamines N-acetyltransferase activity in human colon tumor cells. | 2001 Mar-Apr |
|
Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11). | 2001 May 15 |
|
[Oxidation of indole and its derivatives by heme-independent chloroperoxidases]. | 2001 May-Jun |
|
Report of 19 cases of photoallergic contact dermatitis to sunscreens seen at the Skin and Cancer Foundation. | 2001 Nov |
|
Functionalized oligoanthranilamides: modular and conformationally controlled scaffolds. | 2001 Sep |
|
Phenazine biosynthesis in Pseudomonas fluorescens: branchpoint from the primary shikimate biosynthetic pathway and role of phenazine-1,6-dicarboxylic acid. | 2001 Sep 26 |
|
Monitoring glycosylation of therapeutic glycoproteins for consistency using highly fluorescent anthranilic acid. | 2002 |
|
Photocyclization of N,N-phthaloylanthranilic amides coupled to omega-amino acids with increasing chain lengths. | 2002 Apr |
|
Location of abasic sites in oligodeoxynucleotides by tandem mass spectrometry and by a chemical cleavage initiated by an unusual reaction of the ODN with MALDI matrix. | 2002 Dec |
|
Induction of anthranilate synthase activity by elicitors in oats. | 2002 Jan-Feb |
|
Role of rhizobial biosynthetic pathways of amino acids, nucleotide bases and vitamins in symbiosis. | 2002 Jul |
|
Modification of carbon nanofibres for the immobilization of metal complexes: a case study with rhodium and anthranilic acid. | 2002 Jul 2 |
|
[Structural variation of o-amino-benzoic acid induced by free electron laser]. | 2002 Jun |
|
The catalytic mechanism of indole-3-glycerol phosphate synthase: crystal structures of complexes of the enzyme from Sulfolobus solfataricus with substrate analogue, substrate, and product. | 2002 Jun 7 |
|
Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure. | 2002 Mar |
|
Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides. | 2002 Nov 15 |
|
Yeast D-amino acid oxidase: structural basis of its catalytic properties. | 2002 Nov 29 |
|
Allergic contact dermatitis from etofenamate without cross-sensitization to other anthranilic acid derivatives. | 2003 |
|
Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity. | 2003 Aug 1 |
|
S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates. | 2003 Aug 1 |
|
Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors. | 2003 Feb 10 |
|
High-performance liquid chromatography assay for 1-deoxy-D-xylulose 5-phosphate synthase activity using fluorescence detection. | 2003 Feb 7 |
|
Kynurenines and the respiratory parameters on rat heart mitochondria. | 2003 Jan 24 |
|
Peptides to peptidomimetics: towards the design and synthesis of bioavailable inhibitors of oligosaccharyl transferase. | 2003 Jan 7 |
|
Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein. | 2003 Jul 1 |
|
Gene cluster of Arthrobacter ilicis Ru61a involved in the degradation of quinaldine to anthranilate: characterization and functional expression of the quinaldine 4-oxidase qoxLMS genes. | 2003 Jul 25 |
|
A quasi-tetrahedral Cu4 cluster and a helical-chain copper (II) complex with single syn-anti carboxylate bridges: crystal structure and magnetic properties. | 2003 Jun 30 |
|
Conjugate additions of o-iodoanilines and methyl anthranilates to acetylenic sulfones. A new route to quinolones including first syntheses of two alkaloids from the medicinal herb Ruta chalepensis. | 2003 Mar 21 |
|
Complexity of coordinative bonding in thallium(I) anthranilates and salicylates. | 2003 Mar 26 |
|
Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors. | 2003 May 1 |
|
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs. | 2003 May 19 |
|
Probing cathepsin K activity with a selective substrate spanning its active site. | 2003 Oct 15 |
|
A concise total synthesis of (+/-)-alantrypinone by a novel hetero-Diels-Alder reaction. | 2003 Sep 4 |
|
Waste-free and facile solid-state protection of diamines, anthranilic acid, diols, and polyols with phenylboronic acid. | 2003 Sep 5 |
|
Production and analysis of organic acids in hairy-root cultures of Isatis indigotica Fort. (indigo woad). | 2004 Feb |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12844171
15,000 or 30,000 ppm for the rats, and either 25,000 or 50,000 ppm for the mice, 5 days per week for 78 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22015263
The DNA damage effects of tryptophan metabolites were analyzed using plasmid relaxation assay performed with anthranilic acid at various concentrations between 50 uM and 400 uM in the presence of plasmid DNA pSP-72. Anthranilic acid did not show any plasmid relaxation activity.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
8530
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C031385
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
100000077403
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
1321
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
30754
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
0YS975XI6W
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
118-92-3
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
227
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
SUB12908MIG
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
144
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
DTXSID8020094
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
ANTHRANILIC ACID
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
40929
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
m1687
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
204-287-5
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY | |||
|
DB04166
Created by
admin on Fri Dec 15 17:19:44 GMT 2023 , Edited by admin on Fri Dec 15 17:19:44 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD